1. Barbour A, Guminski A, Liu W, Menzies S, Morton R, Cancer Council Australia Melanoma Guidelines Working Party. Follow-up After Initial Definitive Treatment for Each Stage of Melanoma–Cancer Guidelines Wiki, 2018. Retrieved 8 March 2022 at https://wiki.cancer.org.au/australiawiki/index.php?oldid=190154.
2. National Comprehensive Cancer Network. NCCN Guidelines Version 2.2022. Melanoma: Cutaneous, 2022.
3. Pflugfelder A, Kochs C, Blum A, et al. Malignant melanoma S3-guideline: diagnosis, therapy and follow-up of melanoma. JDDG J der Dtsch Dermatologischen Gesellschaft. 2013;11:1–116. https://doi.org/10.1111/DDG.12113_SUPPL.
4. Hendel H, Lock-Andersen J, Dahlstrøm K, et al. Opfølgningsprogram for Modermærkekræft. Sundhedsstyrelsen 2015.; 2015. https://www.sst.dk/da/udgivelser/2015/~/media/06A4C4DB820A49F19311C5879672BE7D.ashx.
5. National Institute for Health and Care Excellence (NICE). Melanoma: Assessment and Management NICE Guideline, 2022. Retrieved 7 August 2022 at www.nice.org.uk/guidance/ng14.